Announced Tue, 24 Mar · 10:19 IST

Solara Active Pharma Sciences Limited has informed the Exchange that the Rights issue committee members at its meeting held on March 24, 2026, has approved the making of Second & Final call of ₹ 112.50/- per equity shares (₹ 3.00/- towards face value and ₹ 109.50/- towards securities premium) per Rights Share in respect of partly paid Rights Shares and Fixed the Record date as April 02, 2026 for the same.

Fund Raising View source PDF

SOLARA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.6%1-day move
₹434.90
prior close
₹437.25
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2-0.2-0.4-0.5+4.6+1.4-1.8+5.9+9.2+8.4+12.3+10.0+28.5+31.8
Up moveDown movePending
AI summary

Solara Active Pharma Sciences has announced the second and final call of ₹112.50 per share on its partly paid-up rights equity shares. Out of this, ₹3.00 is towards face value and ₹109.50 towards securities premium. The call is being made pursuant to the original Letter of Offer dated May 9, 2024. The Rights Issue Committee has fixed Thursday, April 2, 2026, as the record date to identify eligible shareholders who will receive the call notice. Shareholders holding partly paid rights shares must pay the balance amount by the due date to make their shares fully paid up. Failure to pay could result in forfeiture of the partly paid shares as per the terms of the issue.

Likely market impact

Eligible shareholders need to arrange funds by the call payment deadline to avoid potential forfeiture of their rights shares. Once the call is paid, their shares will become fully paid-up, increasing the paid-up capital of the company. This is a routine completion step of the 2024 rights issue and is not a new fundraising event.